- Home
- WHWK
as 07-15-2025 4:00pm EST
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | MORRISTOWN |
| Market Cap: | 87.6M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 148.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.91 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.21 - $3.81 | Next Earning Date: | 08-15-2025 |
| Revenue: | $27,775,000 | Revenue Growth: | 16.51% |
| Revenue Growth (this year): | 49.83% | Revenue Growth (next year): | N/A |
Latest Whitehawk Therapeutics Inc. Common Stock News
WHWK Breaking Stock News: Dive into WHWK Ticker-Specific Updates for Smart Investing
PR Newswire
a month ago
Whitehawk Therapeutics to Participate in H.C. Wainwright "HCW@Home" Series
PR Newswire
2 months ago
Whitehawk Therapeutics to Present at the Jefferies 2025 Global Healthcare Conference
PR Newswire
2 months ago
Whitehawk Therapeutics to Participate in the TD Cowen 6th Annual Oncology Innovation Summit
PR Newswire
2 months ago
Whitehawk Reports First Quarter 2025 Financial Results and Recent Highlights
Compare WHWK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "WHWK Whitehawk Therapeutics Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.